Results 11 to 20 of about 270,238 (257)

Stent insertion and balloon angioplasty for portal vein stenosis after liver transplantation: long-term follow-up results

Diagnostic and Interventional Radiology, 2019
PURPOSEIt is not easy to determine whether balloon angioplasty or stenting should be performed in patients with portal vein stenosis after liver transplantation.
Kyeong Sik Kim, Jong Man Kim, Ji Soo Lee, Gyu Sung Choi, Jae-Won Cho, Suk-Koo Lee   +5 more
doaj   +2 more sources

Transcutaneous Puncture of an Undeflatable Coronary Angioplasty Balloon Catheter. [PDF]

Case Rep Cardiol, 2018
This case report describes a quick and safe method to successfully retrieve an undeflatable angioplasty balloon via the transradial access site. The article also presents potential mechanisms of contrast media entrapment and bench tests of guidewire ...
Leibundgut G, Degen C, Riede F.
europepmc   +2 more sources

Combined rotational atherectomy and cutting balloon angioplasty prior to drug‐eluting stent implantation in severely calcified coronary lesions: The PREPARE‐CALC‐COMBO study

Catheterization and cardiovascular interventions, 2022
To evaluate the safety and efficacy of lesion preparation using rotational atherectomy (RA) with consecutive cutting balloon angioplasty (Rota‐Cut).
A. Allali, R. Toelg, M. Abdel-Wahab, R. Hemetsberger, A. Kastrati, N. Mankerious, Hussein Traboulsi, K. Elbasha, Tobias Rheude, M. Landt, V. Geist, G. Richardt   +11 more
semanticscholar   +1 more source

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials

PLoS ONE, 2020
Background Restenosis remains a significant problem in endovascular therapy for hemodialysis vascular access. Drug-coated balloon (DCB) angioplasty decreases restenosis in peripheral and coronary artery diseases.
Min‐Tsun Liao, Meng-Kan Chen, Mu-Yang Hsieh, Nai-Lun Yeh, K. Chien, Chih-Ching Lin, Chih-Cheng Wu, W. Chie   +7 more
semanticscholar   +1 more source

Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease [PDF]

, 1996
BACKGROUND: Excimer laser coronary angioplasty is reported to give excellent procedural results for treatment of complex coronary lesions, but this method has not been compared with balloon angioplasty in a randomised trial.
Appelman, Y.E.A. (Yolande), David, G.K. (George), Feyter, P.J. (Pim) de, Koelemay, M.J.W. (Mark), Koolen, J.J. (Jacques), Margolis, M.P. (Pauliina), Piek, J.J. (Jan), Serruys, P.W.J.C. (Patrick), Strikwerda, S. (Sipke), Swijndregt, E.W.J.M. (Eline W. J. Montauban) van, Tijssen, J.G.P. (Jan)   +10 more
core   +2 more sources

Advances in procedural techniques--antegrade. [PDF]

, 2014
There have been many technological advances in antegrade CTO PCI, but perhaps most importantly has been the evolution of the "hybrid' approach where ideally there exists a seamless interplay of antegrade wiring, antegrade dissection re-entry and ...
Spratt, JC, Wilson, W
core   +1 more source

Exercise right heart catheterization before and after balloon pulmonary angioplasty in inoperable patients with chronic thromboembolic pulmonary hypertension

Pulmonary Circulation, 2020
Background * These authors contributed equally as last authors. Balloon pulmonary angioplasty is an evolving, interventional treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension (CTEPH).
Christoph B. Wiedenroth, MD, Andreas J. Rieth, MD, Steffen Kriechbaum, MD, H.-Ardeschir Ghofrani, MD, Andreas Breithecker, MD, Moritz Haas, MD, Fritz Roller, MD, Manuel J. Richter, MD, Mareike Lankeit, Lisa Mielzarek, Andreas Rolf, MD, Christian W. Hamm, MD, Eckhard Mayer, MD, Stefan Guth, MD, Christoph Liebetrau, MD   +14 more
doaj   +1 more source

ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data. [PDF]

, 2013
A number of risk scores already exist to predict cardiovascular (CV) events. However, scores developed with data collected some time ago might not accurately predict the CV risk of contemporary hypertensive patients that benefit from more modern ...
A K Gupta, AS Levey, B Dahlöf, B Dahlöf, C-L Chang, D Prieto-Merino, D Wood, DW Hosmer, E Falaschetti, EM Antman, G Mancia, H Wedel, J Dobson, J Hippisley-Cox, KM Anderson, MJ Pencina, N Poulter, P Primatesta, P S Sever, PS Sever, PS Sever, R D'Agostino, RB D’Agostino, RM Conroy, S Pocock, SJ Pocock, TC Clayton, TG Clark   +27 more
core   +1 more source

Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching [PDF]

, 2012
Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial.
Angelo Guglielmotti, Antonio Parisi, Armando Ialenti, Carla Cicala, Daniele De Filippis, Francesco Maione, Gianluca Grassia, Marcella Maddaluno, Maria Vittoria Di Lauro, Nicola Mascolo, Olivier Kocher, Pasquale Maffia, Teresa Iuvone   +12 more
core   +6 more sources

Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. [PDF]

, 2014
Cardiovascular disease remains one of the largest contributors to death worldwide. Improvements in cardiovascular technology leading to the current generation of drug-eluting stents, bioresorbable stents, and drug-eluting balloons, coupled with advances ...
Panitch, Alyssa, Scott, Rebecca A
core   +2 more sources